Premium
Bosentan and sildenafil: Should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
Author(s) -
Brancaccio Gianluca,
Toscano Alessandra,
Bevilacqua Maurizio,
Di Chiara Luca,
Parisi Francesco
Publication year - 2007
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2006.00606.x
Subject(s) - sildenafil , bosentan , medicine , prostacyclin , combination therapy , endothelin receptor , receptor
We report a case of a seven‐yr‐old girl with a PAH treated with continuation therapy of bosentan and sildenafil. The combination therapy revealed safety and efficacy in long‐term follow up.